These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31999902)

  • 1. The Burden of Cough and Phlegm in People With COPD: A COPD Patient-Powered Research Network Study.
    Choate R; Pasquale CB; Parada NA; Prieto-Centurion V; Mularski RA; Yawn BP
    Chronic Obstr Pulm Dis; 2020 Jan; 7(1):49-59. PubMed ID: 31999902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
    Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm.
    de Marco R; Accordini S; Cerveri I; Corsico A; Antó JM; Künzli N; Janson C; Sunyer J; Jarvis D; Chinn S; Vermeire P; Svanes C; Ackermann-Liebrich U; Gislason T; Heinrich J; Leynaert B; Neukirch F; Schouten JP; Wjst M; Burney P
    Am J Respir Crit Care Med; 2007 Jan; 175(1):32-9. PubMed ID: 17008642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical determinants of exacerbations in severe, early-onset COPD.
    Foreman MG; DeMeo DL; Hersh CP; Reilly JJ; Silverman EK
    Eur Respir J; 2007 Dec; 30(6):1124-30. PubMed ID: 17715170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic productive cough is associated with death in smokers with early COPD.
    Putcha N; Drummond MB; Connett JE; Scanlon PD; Tashkin DP; Hansel NN; Wise RA
    COPD; 2014 Aug; 11(4):451-8. PubMed ID: 24127996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cough and phlegm are important predictors of health status in smokers without COPD.
    Heijdra YF; Pinto-Plata VM; Kenney LA; Rassulo J; Celli BR
    Chest; 2002 May; 121(5):1427-33. PubMed ID: 12006424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.
    Melzer AC; Feemster LC; Crothers K; Carson SS; Gillespie SE; Henderson AG; Krishnan JA; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Pickard AS; Au DH;
    Ann Am Thorac Soc; 2016 Sep; 13(9):1490-6. PubMed ID: 27268422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.
    Chang CH; Chuang LP; Lin SW; Lee CS; Tsai YH; Wei YF; Cheng SL; Hsu JY; Kuo PH; Yu CJ; Chen NH
    BMC Pulm Med; 2016 Aug; 16(1):118. PubMed ID: 27501837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials.
    Park J; Lee JS; Rhee C; Oh YM
    J Korean Med Sci; 2015 Oct; 30(10):1453-8. PubMed ID: 26425042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease.
    Yount SE; Atwood C; Donohue J; Hays RD; Irwin D; Leidy NK; Liu H; Spritzer KL; DeWalt DA
    J Patient Rep Outcomes; 2019 Oct; 3(1):65. PubMed ID: 31664536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD.
    Johnson KM; Safari A; Tan WC; Bourbeau J; FitzGerald JM; Sadatsafavi M; Study OBOTCCOOLDC;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3983-3995. PubMed ID: 30587954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD: an underdiagnosed disease at hospital environment.
    Kart L; Akkoyunlu ME; Bayram M; Yakar F; Kutbay Özçelik H; Karaköse F; Sezer M
    Wien Klin Wochenschr; 2014 Feb; 126(3-4):73-8. PubMed ID: 24249327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome.
    Kurashima K; Takaku Y; Ohta C; Takayanagi N; Yanagisawa T; Sugita Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():479-87. PubMed ID: 27019598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.